Elanco Animal Health Inc
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
ELAN$26.76-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
| Common Stock · Accumulated Other Comprehensive Loss | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-in Capital | Accumulated Deficit | Cash Flow Hedges | Foreign Currency Translation | Defined Benefit Plans | Total | Total Equity | |
| December 31, 2022 | 474.2 | $— | $8,738 | $(1,057) | $182 | $(672) | $98 | $(392) | $7,289 |
| Net income | — | — | — | 103 | — | — | — | — | 103 |
| Other comprehensive income (loss), net of tax | — | — | — | — | (48) | 130 | — | 82 | 82 |
| Stock-based compensation activity, net | 1.0 | — | 6 | — | — | — | — | — | 6 |
| Conversion of tangible equity units (TEUs) into common stock | 17.2 | — | — | — | — | — | — | — | — |
| March 31, 2023 | 492.4 | — | 8,744 | (954) | 134 | (542) | 98 | (310) | 7,480 |
| Net loss | — | — | — | (97) | — | — | — | — | (97) |
| Other comprehensive income (loss), net of tax | — | — | — | — | 29 | 2 | (2) | 29 | 29 |
| Stock-based compensation activity, net | 0.2 | — | 8 | — | — | — | — | — | 8 |
| June 30, 2023 | 492.6 | $— | $8,752 | $(1,051) | $163 | $(540) | $96 | $(281) | $7,420 |
| December 31, 2023 | 492.8 | $— | $8,777 | $(2,288) | $57 | $(379) | $56 | $(266) | $6,223 |
|---|---|---|---|---|---|---|---|---|---|
| Net income | — | — | — | 32 | — | — | — | — | 32 |
| Other comprehensive (loss) income, net of tax | — | — | — | — | 32 | (227) | (4) | (199) | (199) |
| Stock-based compensation activity, net | 1.2 | — | — | — | — | — | — | — | — |
| March 31, 2024 | 494.0 | — | 8,777 | (2,256) | 89 | (606) | 52 | (465) | 6,056 |
| Net loss | — | — | — | (50) | — | — | — | — | (50) |
| Other comprehensive loss, net of tax | — | — | — | — | (9) | (66) | (2) | (77) | (77) |
| Stock-based compensation activity, net | 0.2 | — | 13 | — | — | — | — | — | 13 |
| June 30, 2024 | 494.2 | $— | $8,790 | $(2,306) | $80 | $(672) | $50 | $(542) | $5,942 |
2024 Q2 Form 10-Q | 7
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.